1-10 of 10
Paul Kussie
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Neutralizing antibody against FGFR3 shows anti-tumor effects in multiple tumor models in vivo

Roberto DiRenzo, Maria Malabunga, Marie Prewett, Rajiv Bassi, David Surguladze, Juqun Shen, James Tonra, Paul Kussie, Haijun Sun
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 2080.
Published: 01 May 2007
View article titled, Neutralizing antibody against FGFR3 shows anti-tumor effects in multiple tumor models <em>in vivo</em>
Journal Articles

Fibroblast growth factor-signaling in osteosarcoma tumor cells

Kyung Yu, Maria Malabunga, Roberto Direnzo, Paul Balderes, Venkat Mangalampalli, Yaron Hadari, Paul Kussie, Haijun Sun
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 711.
Published: 15 April 2006
View article titled, Fibroblast growth factor-signaling in osteosarcoma tumor cells
Journal Articles

Inhibitory activity of the anti-epidermal growth factor receptor (EGFR) antibody Erbitux® on EGFR kinase domain mutants

Jacqueline Doody, Cindy Wang, Sheetal Patel, Robin Rolser, Cindy Chiang, Kun Hu, Michelle Iacolina, Larry Witte, Peter Bohlen, Daniel J. Hicklin, Paul Kussie, Yaron R. Hadari
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1191–1192.
Published: 01 May 2005
View article titled, Inhibitory activity of the anti-epidermal growth factor receptor (EGFR) antibody Erbitux® on EGFR kinase domain mutants
Journal Articles

Specific VE-cadherin epitopes govern antiangiogenic or toxic responses to various VE-cadherin antibodies on tumor and normal vasculature

Chad May, Xiaohong Xu, Peter Chien Chen, Andrea Hooper, Rowena Almonte-Baldonado, Paul Kussie, Larry Shapiro, Daniel J. Hicklin, Peter Bohlen
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 708.
Published: 01 May 2005
View article titled, Specific VE-cadherin epitopes govern antiangiogenic or toxic responses to various VE-cadherin antibodies on tumor and normal vasculature
Journal Articles

Activity of small molecule inhibitors of the epidermal growth factor receptor (EGFR) kinase, on EGFR kinase domain mutants

Jacqueline Doody, Robin Rolser, Sheetal Patel, Cindy Wang, Cindy Chiang, Kun Hu, Leon Smith, Sabina Burdzovic-Wizmann, Larry Witte, Peter Bohlen, Daniel J. Hicklin, Paul Kussie, Yaron R. Hadari
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1250.
Published: 01 May 2005
View article titled, Activity of small molecule inhibitors of the epidermal growth factor receptor (EGFR) kinase, on EGFR kinase domain mutants
Journal Articles

Regulation of heparanase expression and secretion by protein kinase A and protein kinase C

Hua-Quan Miao, Elizabeth Navarro, Frank Schmitges, Yaron Hadari, Peter Bohlen, Paul Kussie
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 415–416.
Published: 01 April 2004
View article titled, Regulation of heparanase expression and secretion by protein kinase A and protein kinase C
Journal Articles

A fully human monoclonal antibody against VEGFR-1 inhibits growth of human breast cancers

Yan Wu, Zhaojing Zhong, Huiling Li, James Huber, Rajiv Bassi, Andrea Hooper, Bridget Finnerty, Xenia Jimenez, Henry Koo, Paul Balderes, Dale Ludwig, Paul Kussie, Larry Witte, Peter Bohlen, Daniel J. Hicklin
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 694–695.
Published: 01 April 2004
View article titled, A fully human monoclonal antibody against VEGFR-1 inhibits growth of human breast cancers
Journal Articles

A Fully Human Monoclonal Antibody to the Insulin-Like Growth Factor I Receptor Blocks Ligand-Dependent Signaling and Inhibits Human Tumor Growth in Vivo

Douglas Burtrum, Zhenping Zhu, Dan Lu, Donna Marie Anderson, Marie Prewett, Daniel S. Pereira, Rajiv Bassi, Rashed Abdullah, Andrea T. Hooper, Henry Koo, Xenia Jimenez, Danielle Johnson, Robin Apblett, Paul Kussie, Peter Bohlen, Larry Witte, Daniel J. Hicklin, Dale L. Ludwig
Journal: Cancer Research
Cancer Res (2003) 63 (24): 8912–8921.
Published: 24 December 2003
View article titled, A Fully Human Monoclonal Antibody to the Insulin-Like Growth Factor I Receptor Blocks Ligand-Dependent Signaling and Inhibits Human Tumor Growth <em>in Vivo</em>
Open the PDF for A Fully Human Monoclonal Antibody to the Insulin-Like Growth Factor I Receptor Blocks Ligand-Dependent Signaling and Inhibits Human Tumor Growth <em>in Vivo</em> in another window
Journal Articles

High Heparanase Activity in Multiple Myeloma Is Associated with Elevated Microvessel Density

Thomas Kelly, Hua-Quan Miao, Yang Yang, Elizabeth Navarro, Paul Kussie, Yan Huang, Veronica MacLeod, Jonathan Casciano, Lija Joseph, Fenghuang Zhan, Maurizio Zangari, Bart Barlogie, John Shaughnessy, Ralph D. Sanderson
Journal: Cancer Research
Cancer Res (2003) 63 (24): 8749–8756.
Published: 24 December 2003
View article titled, High Heparanase Activity in Multiple Myeloma Is Associated with Elevated Microvessel Density
Open the PDF for High Heparanase Activity in Multiple Myeloma Is Associated with Elevated Microvessel Density in another window
Journal Articles

Selective Targeting of Angiogenic Tumor Vasculature by Vascular Endothelial-cadherin Antibody Inhibits Tumor Growth without Affecting Vascular Permeability

Fang Liao, Jacqueline F. Doody, Jay Overholser, Bridget Finnerty, Rajiv Bassi, Yan Wu, Elisabetta Dejana, Paul Kussie, Peter Bohlen, Daniel J. Hicklin
Journal: Cancer Research
Cancer Res (2002) 62 (9): 2567–2575.
Published: 01 May 2002
View article titled, Selective Targeting of Angiogenic Tumor Vasculature by Vascular Endothelial-cadherin Antibody Inhibits Tumor Growth without Affecting Vascular Permeability
Open the PDF for Selective Targeting of Angiogenic Tumor Vasculature by Vascular Endothelial-cadherin Antibody Inhibits Tumor Growth without Affecting Vascular Permeability in another window
Includes: Supplementary data